We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Magnetic Resonance Targeting Therapy Could Transform Cancer Treatment

By HospiMedica International staff writers
Posted on 24 Aug 2015
Researchers at the University of Sheffield have found a way to use Magnetic Resonance Imaging (MRI) scanners to direct cell-based, tumor-killing therapies to primary and secondary cancer sites in the body.

The international research team was led by scientists at the University of Sheffield’s (Sheffield, UK) Department of Oncology and was funded by the UK Medical Research Council (MRC). More...
The team was able to demonstrate an 800% increase in the effectiveness of cancer therapy using the new MRI-steering technique. The immune cells contained Super-Paramagnetic Iron Oxide (SPIOs) nanoparticles, and the Oncolytic Virus (OV) which infects and kills cancer cells.

The research made use of mouse models, and was published in August 2015, in the journal Nature Communications. The research was carried out in collaboration with University College London (London, UK) and University College London Comprehensive Cancer Imaging Center and the University of Florida (USA).

Dr. Munitta Muthana, University of Sheffield, said, “Our results suggest that it is possible to use a standard MRI scanner to naturally deliver cell-based therapies to both primary and secondary tumors which would normally be impossible to reach by injection. This not only increases the therapeutic efficacy but also decreases the risk of unwanted side effects. The beauty of using the MRI scanner to administer the therapy is that you can also use it for its original purpose providing a real-time image-guide to ensure the treatment has gone where it is needed”.

Related Links:

The University of Sheffield
UCL and UCL Comprehensive Cancer Imaging Center
University of Florida




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.